In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany

Chemotherapy

Volumn 47, Issue 2, 2001, Pages 104-109

  Lemmen, Sebastian ^a   Al Lahham, Adnan ^a   Lütticken, Rudolf ^a   Reinert, Ralf René ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Gemifloxacin; Germany; In vitro activity; Pneumococci; Streptococcus pneumoniae

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN; GEMIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; SPARFLOXACIN; TETRACYCLINE;

ANTIMICROBIAL ACTIVITY; ARTICLE; GERMANY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; ERYTHROMYCIN; FLUOROQUINOLONES; GERMANY; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE; TETRACYCLINE;

EID: 0035128058     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048508     Document Type: Article

References (21)

1. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: Update (1990 to 1996)
2. Pneumococcal antimicrobial resistance: The problem in Hungary
3. Antimicrobial resistance and type distribution of Streptococcus pneumoniae isolates causing systemic infections in Germany, 1992-1994
4. Antimicrobial resistance of Streptococcus pneumoniae recovered from respiratory tract infections (RTI) of outpatients in Germany, 1998-1999: Results of a 20-center national surveillance study
5. Penicillin-resistant pneumococcus in community-acquired bacteremic pneumonia in Germany
6. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens - Findings of the Alexander Project 1992-1996
7. Antimicrobial activity and spectrum of LB20304. A novel fluoronaphthyridone
8. Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci
9. Antipneumococcal activities of gemifloxacin compared to those of nine other agents
10. The in vitro activity and tentative breakpoint of gemifloxacin, a new fluoroquinolone
11. In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas
12. In vitro activities of gemifloxacin (SB 265805, LB20304) against recent clinical isolates of Chlamydia pneumoniae
13. In vitro and in vivo evaluations of LB20304, a new fluoronaphthyridone
14. In vitro activity of gemifloxacin (SB 265805) against anaerobes
15. Anti-streptococcal activity of SB-265805 (LB20304), a novel fluoronaphthyridone, compared with five other compounds, including quality control guidelines
16. A comparative study of the in vitro activity of levofloxacin against Streptococcus pneumoniae
17. Moxifloxacin: A comparison with other fluoroquinolones of the in vitro activity against Streptococcus pneumoniae
18. Activity of gemifloxacin against penicillin- and ciprofloxacin-resistant Streptococcus pneumoniaedisplaying topoisomerase- and efflux-mediated resistance mechanisms
19. Gemifloxacin is effective in experimental pneumococcal meningitis
20. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian bacterial surveillance network